Related Experiment Video
Updated: Sep 19, 2025

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
Emerging Techniques in the Treatment of Conjunctival Melanoma
Wendy J Li1, Nandini Venkateswaran2, Michael Antonietti1
1Department of Ophthalmology, Bascom Palmer Eye Institute, 900 NW 17 thStreet, Miami, FL 33136 USA.
Purpose Of Review:
In this article, we summarize the pathogenesis, diagnostic challenges, current management, and emerging therapeutic strategies for conjunctival melanoma (CM).
Recent Findings:
CM is a deadly disease with rising global incidence. Key mutations, including BRAF, NF1, and TERT, play crucial roles in CM pathogenesis and may serve as targets for therapy. Advanced imaging and histopathological analysis have improved early detection and prognostic assessment. Treatment depends on tumor stage and includes surgical excision with adjuvant chemotherapy, radiotherapy, or orbital exenteration in advanced cases. Systemic workup is always indicated. Immune checkpoint inhibitors, successful in cutaneous melanoma, show promise in CM based off early studies, although more research is needed to confirm their benefit.
Summary:
CM remains a significant clinical challenge and requires a multidisciplinary approach to diagnosis and treatment. Incorporating genetic profiling and targeted therapies is crucial to improving patient outcomes.
Insights
Conjunctival melanoma (CM) is a serious cancer with increasing incidence. Advances in genetic profiling and targeted therapies offer new hope for improved patient outcomes in managing this challenging disease.
Area of Science:
- Ophthalmology
- Oncology
- Genetics
Background:
- Conjunctival melanoma (CM) presents a growing global health concern with significant mortality.
- Understanding the key genetic mutations (BRAF, NF1, TERT) is vital for CM pathogenesis and therapeutic targeting.
Purpose of the Study:
- To review the pathogenesis, diagnostic difficulties, current management, and novel therapeutic strategies for conjunctival melanoma.
- To highlight the importance of a multidisciplinary approach and emerging treatments for CM.
Main Methods:
- Review of current literature on conjunctival melanoma.
- Analysis of diagnostic advancements including imaging and histopathology.
- Evaluation of established and experimental therapeutic interventions.
Main Results:
- Key mutations (BRAF, NF1, TERT) are implicated in CM pathogenesis and represent potential therapeutic targets.
- Advanced diagnostic tools improve early detection and prognosis.
- Treatment strategies range from surgical excision to systemic therapies, including promising immune checkpoint inhibitors.
Conclusions:
- Conjunctival melanoma necessitates a multidisciplinary approach for optimal diagnosis and treatment.
- Integrating genetic profiling and targeted therapies is essential for enhancing patient outcomes.
- Further research is required to confirm the efficacy of emerging treatments like immune checkpoint inhibitors in CM.
More Related Videos
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

